Tuesday, April 24, 2018 9:33:12 PM
Excellent job to the current management. NHS, inventory, contacts, and I really loved the number they released for anticipated revenue.
Looking at the insider roster it reads like a medical journal.
Wonder what share price this company can reach this year? Maybe .30?
Maybe 1.00?
Whatever, at least the news is not good, rather it is great!
Wheee!
Recent VYST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM